Maarten M J Wijnenga

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Prognostic Factors

Patient Reported Outcomes

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Thijs van der Vaart, Maarten M J Wijnenga, Karin A van Garderen, Hendrikus Jan Dubbink, Pim J French, Marion Smits, Clemens M F Dirven, Johan M Kros, Arnaud J P E Vincent, Martin J Van Den Bent
Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Thijs van der Vaart, Maarten M J Wijnenga, Karin A van Garderen, Hendrikus Jan Dubbink, Pim J French, Marion Smits, Clemens M F Dirven, Johan M Kros, Arnaud J P E Vincent, Martin J Van Den Bent
Differences in the prognostic role of age, extent of resection and tumor grade between astrocytoma IDHmt and oligodendroglioma: a single center cohort study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Maarten M J Wijnenga, Sybren L N Maas, Vera van Dis, C Mircea S Tesileanu, Johan M Kros, Linda Dirven, Hans M Hazelbag, Hendrikus J Dubbink, Arnaud J P E Vincent, Pim J French, Martin J van den Bent
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation. Neuro-oncology advances 5 (1) (2023)
Maarten M J Wijnenga, Sebastian R van der Voort, Pim J French, Stefan Klein, Hendrikus J Dubbink, Winand N M Dinjens, Peggy N Atmodimedjo, Marius de Groot, Johan M Kros, Joost W Schouten, Clemens M F Dirven, Arnaud J P E Vincent, Marion Smits, Martin J van den Bent
Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. Neuro-oncology advances 1 (1) (2019)